Guardian Pharmacy Services, Inc. (GRDN)

NYSE: GRDN · Real-Time Price · USD

37.93

+0.45 (1.20%)

Aug 21, 2026, 4:00 PM EDT - Market closed

GRDN Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	89.81	65.62	4.66	0.75	0.61	15.01
Cash & Short-Term Investments	89.81	65.62	4.66	0.75	0.61	15.01
Cash Growth	377.26%	1308.13%	519.68%	23.89%	-95.96%	132.78%
Accounts Receivable	103.77	101.61	97.15	77.26	67.83	55.25
Receivables	103.77	101.61	97.15	77.26	67.83	55.25
Inventory	50.44	43.36	40.55	36.73	41.44	33.09
Other Current Assets	10.65	11.04	9.62	14.86	10.12	8.52
Total Current Assets	254.67	221.63	151.99	129.61	120	111.87
Property, Plant & Equipment	88.89	90.17	78.96	73.18	65.19	51.72
Goodwill	79.74	79.74	69.3	56.05	56.05	54.63
Other Intangible Assets	16.62	18.48	14.91	11.98	14.44	17.09
Long-Term Deferred Tax Assets	2.2	2.2	5.27	-	-	-
Other Long-Term Assets	1.46	0.44	0.38	0.36	0.44	0.53
Total Assets	443.58	412.66	320.81	271.17	256.11	235.85

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	108.21	116.21	102.42	85.6	78.1	64.62
Accrued Expenses	15.09	15.05	14.43	16.96	13.95	14.57
Short-Term Debt	-	-	-	9	4	-
Current Portion of Long-Term Debt	-	-	-	3.98	3.96	3.71
Current Portion of Leases	7.38	11.03	10.62	10.14	8.38	8.22
Other Current Liabilities	23.37	18.42	16.65	12.33	3.62	20.42
Total Current Liabilities	154.04	160.7	144.12	138.02	112.01	111.54
Long-Term Debt	-	-	-	18.99	22.97	26.99
Long-Term Leases	31.89	33.69	26.71	27.04	23.67	16.12
Other Long-Term Liabilities	-	0.34	-	27.26	21.54	27.88
Total Liabilities	185.94	194.73	170.83	211.31	180.19	182.53

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.06	0.06	0.06	28.21	42.73	24.11
Additional Paid-In Capital	144.04	139.35	125.48	-	-	-
Retained Earnings	101.51	66.34	17.12	-	-	-
Comprehensive Income & Other	-	-	-	-	-	-0.19
Total Common Equity	245.61	205.76	142.67	28.21	42.73	23.93
Minority Interest	12.03	12.17	7.31	31.65	33.2	29.39
Shareholders' Equity	257.64	217.92	149.98	59.86	75.93	53.32
Total Liabilities & Equity	443.58	412.66	320.81	271.17	256.11	235.85

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	39.27	44.72	37.33	69.15	62.98	55.04
Net Cash (Debt)	50.54	20.9	-32.67	-68.4	-62.38	-40.03
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.79	0.33	-0.53	-	-	-
Filing Date Shares Outstanding	63.34	63.32	63.29	-	-	-
Total Common Shares Outstanding	63.33	63.32	63.29	-	-	-
Working Capital	100.63	60.93	7.86	-8.41	7.99	0.33
Book Value Per Share	3.88	3.25	2.25	-	-	-
Tangible Book Value	149.25	107.54	58.46	-39.82	-27.76	-47.8
Tangible Book Value Per Share	2.36	1.70	0.92	-	-	-
Machinery	-	120.98	110.52	99.95	88.15	77.61
Leasehold Improvements	-	22.39	17.35	14.04	12.29	8.71

SEC Filings: 10-K · 10-Q